Kimberly-Clark to buy Tylenol maker Kenvue for $40bn
The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.